Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $107.2830 (-1.48%) ($105.7603 - $110.1080) on Mon. Mar. 19, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.57% (three month average) | RSI | 37 | Latest Price | $107.2830(-1.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.1% a day on average for past five trading days. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) VYM(50%) IVE(48%) SPLV(48%) IWD(47%) | Factors Impacting ABBV price | ABBV will decline at least -1.285% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-10%) DIA(-6%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.285% (StdDev 2.57%) | Hourly BBV | 0 () | Intraday Trend | -1.5% | | | |
|
Resistance Level | $111.78 | 5 Day Moving Average | $110.96(-3.31%) | 10 Day Moving Average | $111.35(-3.65%) | 20 Day Moving Average | $111.78(-4.02%) | To recent high | -9.1% | To recent low | 16.7% | Market Cap | $189.278b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |